Gentiva closes acquisition of Odyssey HealthCare

NewsGuard 100/100 Score

Gentiva Health Services, Inc. (Nasdaq: GTIV) ("Gentiva" or "the Company"), a leading provider of home health and hospice services, today announced the closing of its acquisition of Odyssey HealthCare, Inc. (Nasdaq: ODSY) ("Odyssey") in an all cash transaction for a price of $27 per share of Odyssey common stock, without interest, for an aggregate purchase price of approximately $1.0 billion, including fees and expenses.

The combination of Gentiva and Odyssey creates the largest US healthcare provider of home health and hospice services based on revenue.  Annualized pro forma revenues for the twelve months ended July 4, 2010 exceeded $1.88 billion, of which approximately 59% related to home health services and approximately 41% related to hospice services.  The combined hospice operations of Odyssey and Gentiva provide care to an average daily patient census of approximately 14,000 in 30 states.  Gentiva raised approximately $1.1 billion in new debt financing to fund the purchase price and refinance existing debt.  

"I would like to welcome all of the Odyssey employees to the Gentiva family and I look forward to building the best home care company in America with their help," commented Gentiva CEO Tony Strange.  "This is truly a transformational transaction for both companies, creating the largest home health and hospice company in the US, providing service to over 330,000 patients and families annually.  Given both companies positive track records, I expect integration will move quickly and seamlessly."

SOURCE Gentiva Health Services, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness